. 2020 Apr;61(4):613–619. doi: 10.2967/jnumed.119.233288

TABLE 3.

Comparison of Dose Estimates Calculated in Current Study with Dose Estimates Reported for Other Published Intravenous ¹⁸F−FDG Dosimetry

Site	Current study	FDA package insert (1)	Jones 1982 (21)	Mejia 1991 (22)	Deloar 1998 (23)	Hays 2002 (24)	Khamwan 2010 (25)	Velasques2010 (26)	Mattsson 2015 (27)
n	9	Unknown	11	8	6	Unknown	35	97	Unknown
Adrenals	1.02E−02 ± 4.65E−03	1.3E−02^*		1.8E−02^*	1.6E−02^*				1.2E−02^*
Brain	4.20E−02 ± 8.91E−03	1.9E−02	2.2E−02	2.9E−02	3.7E−02	3.5E−02		4.6E−02^*	3.8E−02
Breasts	8.84E−03 ± 8.24E−04	9.2E−03^*		1.0E−02^*	1.0E−02^*		7.3E−03	7.7E−03	8.8E−03
Gallbladder wall	1.33E−02 ± 1.40E−03	1.3E−02							1.3E−02
LLI wall	1.44E−02 ± 1.66E−03	1.4E−02		1.8E−02^*	1.5E−02^*				1.4E−02
Small intestine	1.35E−02 ± 1.32E−03	1.3E−02		1.7E−02^*	1.5E−02^*				1.2E−02
Stomach wall	1.42E−02 ± 1.32E−03	1.3E−02		1.5E−02^*	1.2E−02		1.2E−02		1.1E−02
ULI wall	1.33E−02 ± 1.58E−03	1.2E−02		1.7E−02^*	1.5E−02^*				1.2E−02
Heart wall	3.28E−02 ± 1.57E−02	5.9E−02^*	4.3E−02^*	4.5E−02^*	1.7E−02	3.5E−02^*		6.9E−02^*	6.7E−02^*
Kidneys	2.29E−02 ± 5.11E−03	2.0E−02	2.3E−02^*	3.0E−02^*	2.8E−02^*	5.9E−03	2.7E−02^*	7.4E−02^*	1.7E−02
Liver	1.50E−02 ± 1.98E−03	1.6E−02^*	2.0E−02^*	2.3E−02^*	1.8E−02^*	8.4E−03	3.0E−02^*	2.4E−02^*	2.1E−02^*
Lungs	1.38E−02 ± 3.31E−03	1.7E−02^*	2.1E−02^*	1.1E−02	1.8E−02^*	8.4E−03	4.6E−03	1.5E−02^*	2.0E−02^*
Muscle	8.89E−03 ± 1.24E−03	1.1E−02^*							1.0E−02^*
Ovaries	1.13E−02 ± 3.21E−04	1.4E−02^*	1.4E−02^*		1.6E−02^*	1.5E−03^*	1.1E−02		1.4E−02^*
Pancreas	1.40E−02 ± 4.08E−03	2.6E−02^*		2.0E−02^*	2.6E−02^*	1.6E−03			1.3E−02
Red marrow	8.74E−03 ± 1.15E−03	1.3E−02^*	1.4E−02^*	1.2E−02^*	5.6E−03	1.7E−03	1.8E−02^*	1.1E−02^*	1.1E−02^*
Osteogenic cells	1.39E−02 ± 2.37E−03	4.1E−02^*		1.5E−02^*	8.0E−03		2.1E−02^*	1.1E−02	1.1E−02
Skin	6.90E−03 ± 1.01E−03	8.1E−03^*					1.1E−03		7.8E−03^*
Spleen	1.35E−02 ± 3.45E−03	3.8E−02^*	4.3E−02^*	2.2E−02^*	1.4E−02^*	2.1E−03	1.5E−02^*		1.1E−02
Testes	8.63E−03 ± 2.55E−03	1.1E−02^*	1.8E−02^*	1.5E−02^*	1.5E−02^*	1.5E−03	1.1E−02^*	1.1E−02^*	1.1E−02^*
Thymus	9.72E−03 ± 1.76E−03	1.2E−02^*			1.2E−02^*				1.2E−02^*
Thyroid	9.99E−03 ± 3.12E−03	1.1E−02^*		1.3E−02^*	1.3E−02^*		1.0E−02^*	1.0E−02^*	1.0E−02^*
Bladder wall	8.46E−02 ± 1.42E−02	8.6E−02^*	1.2E−01^*	1.2E−01^*	3.1E−01^*	4.3E−02	6.4E−02		1.3E−01
Uterus	2.98E−02 ± 8.18E−03	1.7E−02		1.9E−02	1.9E−02				1.8E−02
Total body	1.03E−02 ± 1.44E−03		1.1E−02^*			1.2E−02^*	1.4E−02^*
Effective dose (mSv/MBq)	1.53E−02 ± 1.63E−03	1.8E−02^*		2.4E−02^*	2.9E−02^*		1.5E−02		1.9E−02^*

Higher reported dose than in current study.

FDA = Food and Drug Administration; LLI = lower large intestine; ULI = upper large intestine.

All dose estimates are reported in mSv/MBq.